Clinical Trial

A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2024 (before its estimated March 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, open-label, fixed-sequence phase I clinical study to evaluate the effect of multiple subcutaneous injections of GZR18 Injection on the pharmacokinetics of multiple oral doses of metformin hydrochloride tablets.
Trial Details
NCT Number NCT06670209
Lead Sponsor Gan and Lee Pharmaceuticals, USA
Conditions Type 2 Diabetes
Enrollment 32 participants
Start Date 2024-10-30
Primary Completion 2025-03-19 (estimated)
Study Completion 2025-03-19 (estimated)
Updated on ClinicalTrials.gov 2024-11-01